Walk into any CBD shop or browse any cannabis dispensary and you'll encounter three distinct product categories: full-spectrum, broad-spectrum, and isolate. The differences matter — both for therapeutic effectiveness and for practical concerns like drug testing. Here's what the science says about each.
THC content: Yes (up to 0.3% in hemp-derived; higher in dispensary products)
Contains: CBD + all other cannabinoids (THC, CBG, CBN, CBC) + terpenes + flavonoids
Pros
Cons
Best for: Chronic pain, anxiety, sleep, inflammation, general wellness
THC content: None (THC removed to non-detectable levels)
Contains: CBD + other cannabinoids (CBG, CBN, CBC) + terpenes — THC removed
Pros
Cons
Best for: Patients who need THC-free but want more than isolate; drug-tested employees
THC content: None
Contains: Pure CBD only (99%+ purity) — all other compounds removed
Pros
Cons
Best for: Drug-tested individuals, THC-sensitive patients, those needing precise dosing
The entourage effect hypothesis holds that the full complement of cannabis compounds — cannabinoids, terpenes, flavonoids — work synergistically, producing greater therapeutic effects than any single compound alone. The most direct evidence comes from a 2018 study by Pamplona et al. comparing full-spectrum CBD extract to CBD isolate in epilepsy patients. The full-spectrum group achieved better seizure control at lower doses, with fewer adverse effects.
A 2015 study by Gallily et al. found that full-spectrum cannabis extract showed a bell-shaped dose-response curve for anti-inflammatory effects with CBD isolate — meaning isolate became less effective at higher doses — while full-spectrum extract showed a linear dose-response with no ceiling effect. This has significant practical implications: patients using isolate may find that increasing the dose stops helping or even worsens symptoms.
Standard urine drug tests screen for THC metabolites (THC-COOH), not CBD. Full-spectrum hemp products legally contain up to 0.3% THC — low enough that typical doses are unlikely to trigger a positive test, but not impossible with high doses or sensitive tests. Broad-spectrum and isolate products carry essentially no drug test risk if properly manufactured and third-party tested.
Important caveat: "THC-free" labeling is not always accurate. A 2017 Penn Medicine study found that 26% of CBD products tested contained more THC than labeled. Always verify with a Certificate of Analysis from an independent lab.
For most therapeutic applications, full-spectrum products are the evidence-based first choice — they're more effective at lower doses and have the most research support. Choose broad-spectrum if you need THC-free but want more than isolate. Choose isolate if you're subject to drug testing, are THC-sensitive, or need precise dosing without any psychoactive risk. Regardless of type, always verify with a third-party COA.